I've been asked the same question a hundred times since launching BestDosage: "Which wellness modalities actually work?"
It's a fair question. It's also a loaded one, because "work" means different things in different contexts. Acupuncture "works" for chronic pain but the evidence for fertility support is thinner. Cryotherapy "works" for mood but the fat-burning claims are dubious. Functional medicine "works" for some patients in some studies but lacks the large-scale RCTs that would satisfy a purist.
So instead of giving you a simple yes/no for each modality, I built a ranking system. I read over 400 studies — systematic reviews, meta-analyses, and landmark RCTs — and scored every major wellness modality on three dimensions: evidence quality, safety profile, and clinical relevance.
I'm a chemist. This is what I do. I measure things.
The Scoring Methodology
Each modality receives a score from A to F across three criteria:
Evidence Quality (EQ): Based on the strength of published research. A = multiple high-quality RCTs and meta-analyses. B = some RCTs with positive results. C = observational studies and small RCTs. D = case reports and preliminary data. F = no meaningful clinical evidence.
Safety Profile (SP): Based on documented adverse events and risk-benefit ratio. A = excellent safety record with minimal adverse events. B = good safety with known manageable risks. C = moderate risks requiring professional supervision. D = significant risks requiring careful screening. F = unacceptable risk profile.
Clinical Relevance (CR): How broadly applicable is the modality? How many conditions has it demonstrated efficacy for? A = effective for multiple conditions with broad applicability. B = effective for specific conditions. C = niche applications with limited but real evidence. D = very narrow application or marginal benefit.
Tier 1: Strong Evidence (Overall Grade: A/A-)
Acupuncture — EQ: A | SP: A | CR: A
The most researched alternative medicine modality. The 2012 meta-analysis by Vickers et al. (PMID: 22965186) — nearly 18,000 patients across 29 RCTs — established acupuncture's superiority over sham and no-acupuncture controls for chronic pain. Additional strong evidence for chemotherapy-induced nausea (PMID: 16651986), migraine prevention (PMID: 19370583), and osteoarthritis. Safety profile is excellent — serious adverse events are extraordinarily rare when performed by licensed practitioners. This is the gold standard in evidence-based alternative medicine.
Browse acupuncture practitioners →
Chiropractic (Spinal Manipulation) — EQ: A- | SP: B+ | CR: B+
Strong evidence for acute and chronic low back pain — recommended in the 2017 American College of Physicians guidelines (PMID: 28192789) as a first-line non-pharmacological treatment. Good evidence for neck pain and cervicogenic headaches. Safety is generally excellent, though rare but serious adverse events (vertebral artery dissection) have been reported with cervical manipulation — estimated incidence is 1 in 400,000 to 1 in several million manipulations (PMID: 20642715). The risk is low but not zero, which prevents a perfect safety score.
Mindfulness-Based Interventions (MBSR/MBCT) — EQ: A | SP: A | CR: A
Goyal et al.'s 2014 meta-analysis in JAMA Internal Medicine (PMID: 24395196) analyzed 47 RCTs and found moderate evidence that mindfulness meditation programs improved anxiety, depression, and pain. MBCT specifically has strong evidence for preventing depressive relapse (PMID: 26066436). Virtually no adverse events. Broad applicability across mental health, pain, and stress-related conditions. The research here is legitimately impressive.
Cognitive Behavioral Therapy for Insomnia (CBT-I) — EQ: A+ | SP: A | CR: B
Technically not "alternative medicine" — it's the recommended first-line treatment for chronic insomnia per the American Academy of Sleep Medicine. Meta-analysis (PMID: 25535358) showed sustained improvement in sleep onset latency, wake after sleep onset, and sleep efficiency. I include it because many wellness seekers don't know it exists and default to supplements instead. Evidence quality is as strong as it gets.
Tier 2: Good Evidence (Overall Grade: B+/B)
Massage Therapy — EQ: B+ | SP: A | CR: B+
Solid evidence for chronic low back pain (PMID: 25784559), anxiety reduction, and post-surgical recovery. Extremely safe. The limitation is that effects tend to be shorter-lived than some other modalities — benefit duration is measured in days to weeks rather than sustained remission. Still, the risk-benefit ratio is among the best in wellness.
Hyperbaric Oxygen Therapy — EQ: B+ | SP: B | CR: B
Strong evidence for FDA-approved indications: diabetic wound healing (Cochrane review), carbon monoxide poisoning, and decompression sickness. Promising data for traumatic brain injury (PMID: 35085321) and cognitive function. Safety is good with proper protocols but requires pressurized chambers and trained operators. Off-label longevity claims remain preliminary.
Ketamine Therapy (IV/Spravato) — EQ: A- | SP: C+ | CR: B
Among the strongest evidence in modern psychiatry for treatment-resistant depression (PMID: 28493069) and acute suicidal ideation (PMID: 29202655). Rapid onset — hours, not weeks. Scored lower on safety due to dissociative side effects, cardiovascular effects, and abuse potential requiring controlled administration. Clinical relevance is focused primarily on treatment-resistant mood disorders. Exceptional for what it does; what it does is narrow.
Infrared Sauna Therapy — EQ: B | SP: A- | CR: B
Good cardiovascular evidence from the Finnish cohort data (PMID: 25705824), though much of it is from traditional saunas rather than infrared specifically. Solid data for pain and rheumatic conditions (PMID: 18685882). Very safe for most populations. Overblown claims around weight loss and detoxification bring the evidence quality rating down.
Browse infrared sauna studios →
Functional Medicine — EQ: B- | SP: A- | CR: B+
The Cleveland Clinic data (PMID: 31651969) is meaningful but observational. The clinical model is sound — comprehensive testing, root-cause analysis, personalized treatment — but the personalization that makes it effective also makes it hard to study in RCTs. Safety is excellent (it's diagnostic-heavy and intervention-careful). I'd rank the evidence higher if more multi-center RCTs existed. The potential here is enormous; the published proof hasn't caught up yet.
Browse functional medicine practitioners →
Tier 3: Emerging Evidence (Overall Grade: B-/C+)
Cold Water Immersion / Cold Plunge — EQ: B | SP: B- | CR: C+
Strong norepinephrine and dopamine data (PMID: 10751106). Good evidence for exercise recovery (PMID: 35141823). The safety rating reflects real cardiovascular risks — cold shock response, arrhythmia risk in susceptible populations. Clinical relevance is primarily athletic recovery and mood enhancement. The breathwork/mental resilience community has embraced it, but hard clinical outcome data for chronic disease is limited.
PEMF Therapy — EQ: B- | SP: A | CR: C+
FDA-cleared for bone healing since 1979. Good meta-analytic data for chronic pain (PMID: 27445601). Excellent safety profile. Limited by the gap between clinical-grade PEMF devices (well-studied) and consumer PEMF mats (less studied). The research is deep but the translation to consumer products is imperfect.
Browse PEMF therapy providers →
Float Therapy — EQ: B- | SP: A | CR: C+
Laureate Institute data (PMID: 29906286) shows large effect sizes for anxiety reduction. Swedish RCT (PMID: 24594679) demonstrates sustained benefits for stress-related disorders. Very safe. Limited by small study sizes and the need for more replication. Magnesium absorption adds a plausible secondary mechanism. A modality with great potential that needs bigger trials.
Craniosacral Therapy — EQ: C+ | SP: A | CR: C+
Recent RCTs show meaningful results for chronic neck pain (PMID: 27258995), migraine (PMID: 32444033), and fibromyalgia (PMID: 21437197). Exceptionally safe — 5 grams of pressure isn't going to hurt anyone. The theoretical framework (craniosacral rhythm) has poor inter-examiner reliability, but clinical outcomes exceed what the shaky theory would predict. A genuine paradox in evidence-based medicine.
Browse craniosacral therapists →
Rolfing / Structural Integration — EQ: C+ | SP: B+ | CR: C
Small but encouraging RCTs for chronic low back pain (PMID: 25105781) and postural improvement (PMID: 26592218). Fascia science is well-supported. Safety is good — modern Rolfing is significantly gentler than its 1970s reputation. Limited by small study sizes and the challenge of blinding manual therapy trials. Niche but legitimate.
Browse Rolfing practitioners →
Tier 4: Limited Evidence (Overall Grade: C/C-)
Whole-Body Cryotherapy — EQ: C | SP: B | CR: C
The 2017 Cochrane Review (PMID: 28282484) found insufficient evidence for exercise recovery versus passive rest. More recent reviews are modestly positive for pain and mood. The mechanism is primarily neurovascular rather than deep tissue cooling. Safe when properly supervised but equipment incidents have occurred in unregulated settings. Evidence lags behind the marketing by a significant margin.
IV Vitamin Therapy — EQ: C- | SP: B- | CR: C-
Legitimate evidence for specific clinical scenarios: malabsorption conditions, high-dose vitamin C as cancer supportive care (PMID: 29898390), severe dehydration. The generic "wellness drip" for healthy individuals has weak evidence — the Myers' Cocktail RCT (PMID: 19250003) showed no significant benefit for fibromyalgia over placebo. Safety concerns include infection risk from improper compounding. The modality is being oversold for general wellness while the actual evidence-based applications are undermarketed.
Neurofeedback — EQ: C+ | SP: A | CR: C
Promising data for ADHD, with several RCTs showing improvements in attention and impulsivity. Evidence for anxiety, PTSD, and depression is emerging but less robust. Extremely safe. The main limitation is standardization — protocols vary widely between practitioners, making cross-study comparison difficult.
At-Home Ketamine (Sublingual) — EQ: C+ | SP: C | CR: C+
Emerging evidence for depression (PMID: 35045694) but fundamentally different pharmacokinetics from the IV protocol that was validated in landmark trials (PMID: 27589592). Safety concerns around unsupervised dissociative experiences and cardiovascular monitoring gaps. Occupies a regulatory gray area that the FDA has flagged. Potentially valuable as maintenance after in-clinic treatment; problematic as a standalone first-line approach.
What This Ranking Does Not Mean
A lower evidence grade does not mean a modality "doesn't work." It means the published research hasn't yet proven it works with the rigor that higher-graded modalities have achieved. Research takes money, time, and institutional interest. Modalities without pharmaceutical industry funding (which is most of them) face inherent disadvantages in evidence accumulation.
Conversely, a high evidence grade doesn't guarantee that a specific provider delivers quality care. Evidence is about the modality. Quality is about the practitioner. That's why the BDS Score exists — to evaluate the humans, not just the methods.
This ranking will be updated annually as new research publishes. Science isn't static, and neither is this page.
I'm Chad. Your chemist.